Foundation Medicine Inc (NASDAQ:FMI) insider Vincent A. Miller sold 2,349 shares of the stock in a transaction dated Tuesday, January 2nd. The shares were sold at an average price of $64.00, for a total value of $150,336.00. Following the transaction, the insider now directly owns 99,484 shares in the company, valued at approximately $6,366,976. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink.
Foundation Medicine Inc (NASDAQ FMI) opened at $64.95 on Friday. The firm has a market capitalization of $2,285.73, a P/E ratio of -14.53 and a beta of -0.01. The company has a current ratio of 2.24, a quick ratio of 2.03 and a debt-to-equity ratio of 0.47. Foundation Medicine Inc has a 12-month low of $17.50 and a 12-month high of $70.75.
Foundation Medicine (NASDAQ:FMI) last issued its quarterly earnings results on Wednesday, November 1st. The company reported ($0.90) earnings per share (EPS) for the quarter, beating the consensus estimate of ($1.06) by $0.16. The business had revenue of $42.66 million during the quarter, compared to analysts’ expectations of $37.99 million. Foundation Medicine had a negative return on equity of 143.18% and a negative net margin of 119.69%. The firm’s revenue for the quarter was up 45.0% compared to the same quarter last year. During the same period in the previous year, the company posted ($0.90) earnings per share. equities analysts forecast that Foundation Medicine Inc will post -4.44 EPS for the current year.
A number of research firms recently weighed in on FMI. BidaskClub raised Foundation Medicine from a “hold” rating to a “buy” rating in a report on Saturday, September 9th. Zacks Investment Research cut Foundation Medicine from a “hold” rating to a “sell” rating in a research note on Tuesday, October 3rd. One research analyst has rated the stock with a sell rating, two have given a hold rating and three have assigned a buy rating to the company. The company has a consensus rating of “Hold” and an average price target of $45.33.
ILLEGAL ACTIVITY NOTICE: “Vincent A. Miller Sells 2,349 Shares of Foundation Medicine Inc (FMI) Stock” was reported by Ticker Report and is the property of of Ticker Report. If you are accessing this news story on another website, it was illegally stolen and republished in violation of US & international trademark & copyright laws. The legal version of this news story can be accessed at https://www.tickerreport.com/banking-finance/3126776/vincent-a-miller-sells-2349-shares-of-foundation-medicine-inc-fmi-stock.html.
About Foundation Medicine
Foundation Medicine, Inc is a molecular information company. The Company sells products that are enabled by its molecular information platform to physicians and biopharmaceutical companies. It is engaged in the business of delivering molecular information about cancer to its customers. Its platform includes various methods and algorithms for analyzing specimens across various types of cancer.
Receive News & Ratings for Foundation Medicine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Foundation Medicine and related companies with MarketBeat.com's FREE daily email newsletter.